Authors
Loading...
Disrupted cross-bridge kinetics may explain weakness in NEB myopathies; leaves open targeted therapies pending clinical validation.
Key points are not available for this paper at this time.
Ochala et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: